Best CE for post-marketing safety updates

I’m looking for CE that goes beyond mechanism reviews and focuses on real‑world effectiveness and pharmacovigilance — ideally content on interpreting FAERS/Sentinel signals and absolute risk (excess events per 1,000). If you’ve taken a strong course in the past 6 months that sharpened your appraisal of phase IV data without overstating weak signals, I’d appreciate the title/provider. If serious symptoms or urgent safety issues arise, patients should be referred to a licensed professional immediately.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‍​‌⁠‌​‌⁠‌‍‌⁠​‌‌​‍‌‌‍⁠‌‌‍​⁠‌​⁠​​⁠‌‌‌⁠‌⁠‌‌‍​‌​‌‍‌​⁠‌‌‌​⁠​⁠‌‌​⁠‍​​‍​‍‌⁠⁠‌​

I got the most practical reps from FDA’s Sentinel Training and Webinars (https://www.fda.gov/safety/fdas-sentinel-initiative/training-and-webinars); not CE per se, but the case walk‑throughs made it easy to translate FAERS/Sentinel signals into absolute risk per 1,000 without overcalling noise. If you need formal credit, the ISPE pre‑conference short course on signal detection paired nicely to round it out.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠‍​​⁠​‍​⁠‍​​⁠​‌​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​‍‌‍‍⁠​⁠‌​‌‍‌⁠‌​⁠‍‌‌​⁠​⁠‌⁠‌‌‍‍‌‍‍‌‌​⁠‍‌‍‍​‌‌​⁠‌⁠‌⁠‌​⁠‌‌⁠‌⁠‌​‌‌​‍​‍‌⁠⁠‌​

DSRU’s Signal Detection & Benefit–Risk Assessment course (CPD) was the most useful I’ve taken in the past 6 months; they have you turn PRR/ROR into excess events per 1,000 and dissect FAERS/Sentinel signals without overcalling: https://www.dsru.org/education/signal-detection-benefit-risk/. Caveat: it’s UK‑leaning (more EudraVigilance), so I paired it with ISPE’s advanced pharmacoepi short course for a US phase IV lens — cured my ‘volcano plot = verdict’ habit.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠‍​​⁠​‍​⁠‍​​⁠​‌​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌⁠⁠‌​‌⁠‌‌​‌‌​‍‍‌​‌​‌‍⁠​‌​⁠‍‌​⁠⁠‌​‌⁠‌​‌‌‌‌⁠⁠‌⁠‌​‌‍⁠​‌‌​​‌​‍​‌​‍⁠​‍​‍‌⁠⁠‌​

Found DIA’s Benefit–Risk Assessment workshop (Nov): FAERS to ‘absolute risk’ plus Sentinel cases; CE, pricey.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠‍​​⁠​‍​⁠‍​​⁠​‌​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​​​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌​‌‌⁠‌‍‌‌⁠⁠‌​⁠⁠‌​‌‍‌⁠‍​‌​‌‌‌‌‍‌‌​⁠​‌‌‍​‌‍⁠‌‌‍⁠‍‌‌‌⁠​⁠​​‌‍‍​‌⁠​‌​‍​‍‌⁠⁠‌​